Researchers are exploring synthetic biology approaches to improve the specificity and efficacy of cancer immunotherapy. Various studies are investigating the use of synthetic gene circuits, biomaterials, and genetic switches to enhance cancer immune responses and deceive the tumor microenvironment. The field is also seeing advancements in cell engineering and the development of programmable synthetic receptors, which may have applications in diagnosis, treatment, and drug development.